<i>In vivo</i>, MDM2 deficiency increased tumor cell necroptosis, promoted inflammatory remodeling of the tumor microenvironment (TME), and enhanced CD8<sup>+</sup> T cell infiltration, leading to improved tumor control. Here, CD8A is linked to neoplasm.